Literature DB >> 21484430

The homeobox gene HLXB9 is upregulated in a morphological subset of poorly differentiated hepatocellular carcinoma.

Ludwig Wilkens1, Rolf Jaggi, Caroline Hammer, Daniel Inderbitzin, Olivier Giger, Nils von Neuhoff.   

Abstract

The prognostic outcome for hepatocellular carcinoma (HCC) remains poor. Disease progression is accompanied by dedifferentiation of the carcinoma, a process that is not well understood. The aim of this study was to get more insight into the molecular characteristics of dedifferentiated carcinomas using high throughput techniques. Microarray-based global gene expression analysis was performed on five poorly differentiated HCC cell lines compared with non-neoplastic hepatic controls and a set of three cholangiolar carcinoma (CC) cell lines. The gene with the highest upregulation was HLXB9. HLXB9 is a gene of the homeobox genfamily important for the development of the pancreas. RT-PCR confirmed the upregulation of HLXB9 in surgical specimens of carcinoma tissue, suggesting its biological significance. Interestingly, HLXB9 upregulation was primary observed in poorly differentiated HCC with a pseudoglandular pattern compared with a solid pattern HCC or in moderate or well-differentiated HCC. Additional the expression of translated HLXB9, the protein HB9 (NCBI: NP_001158727), was analyzed by western blotting. Expression of HB9 was only detected in the cytoplasm but not in the nuclei of the HCC cells. For validation CC were also investigated. Again, we found an upregulation of HLXB9 in CC cells accompanied by an expression of HB9 in the cytoplasms of these tumor cells, respectively. In conclusion, homeobox HLXB9 is upregulated in poorly differentiated HCC with a pseudoglandular pattern. The translated HB9 protein is found in the cytoplasm of these HCC and CC. We therefore assume HLXB9 as a possible link in the understanding of the development of HCC and CC, respectively.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21484430     DOI: 10.1007/s00428-011-1070-5

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  29 in total

1.  Molecular pathogenesis of human hepatocellular carcinoma.

Authors:  Snorri S Thorgeirsson; Joe W Grisham
Journal:  Nat Genet       Date:  2002-08       Impact factor: 38.330

2.  Cryopreservation of adult human hepatocytes obtained from resected liver biopsies.

Authors:  E Alexandre; C Viollon-Abadie; P David; A Gandillet; P Coassolo; B Heyd; G Mantion; P Wolf; P Bachellier; D Jaeck; L Richert
Journal:  Cryobiology       Date:  2002-04       Impact factor: 2.487

3.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

4.  Expression of cell-cell interacting genes distinguishes HLXB9/TEL from MLL-positive childhood acute myeloid leukemia.

Authors:  S Wildenhain; C Ruckert; S Röttgers; J Harbott; W-D Ludwig; F R Schuster; K Beldjord; V Binder; R Slany; J Hauer; A Borkhardt
Journal:  Leukemia       Date:  2010-07-01       Impact factor: 11.528

5.  Dorsal-ventral patterning during neural induction in Xenopus: assessment of spinal cord regionalization with xHB9, a marker for the motor neuron region.

Authors:  M S Saha; R R Miles; R M Grainger
Journal:  Dev Biol       Date:  1997-07-15       Impact factor: 3.582

6.  Comparison of tumor pathology with duration of survival of North American patients with hepatocellular carcinoma.

Authors:  U C Nzeako; Z D Goodman; K G Ishak
Journal:  Cancer       Date:  1995-08-15       Impact factor: 6.860

7.  Relationship of histologic grade of hepatocellular carcinoma (HCC) to tumor size, and demonstration of tumor cells of multiple different grades in single small HCC.

Authors:  K Kenmochi; S Sugihara; M Kojiro
Journal:  Liver       Date:  1987-02

8.  Molecular signature in three types of hepatocellular carcinoma with different viral origin by oligonucleotide microarray.

Authors:  Norio Iizuka; Masaaki Oka; Hisafumi Yamada-Okabe; Kenji Hamada; Hironobu Nakayama; Naohide Mori; Takao Tamesa; Toshimasa Okada; Norikazu Takemoto; Katsuhiro Matoba; Motonari Takashima; Katsuhiko Sakamoto; Akira Tangoku; Takanobu Miyamoto; Shunji Uchimura; Yoshihiko Hamamoto
Journal:  Int J Oncol       Date:  2004-03       Impact factor: 5.650

9.  The morphologic transition in hepatocellular carcinoma. A comparison of the individual histologic features disclosed by ultrasound-guided fine-needle biopsy with those of autopsy.

Authors:  S Sugihara; O Nakashima; M Kojiro; Y Majima; M Tanaka; K Tanikawa
Journal:  Cancer       Date:  1992-09-15       Impact factor: 6.860

10.  Expression profiling with RNA from formalin-fixed, paraffin-embedded material.

Authors:  Andrea Oberli; Vlad Popovici; Mauro Delorenzi; Anna Baltzer; Janine Antonov; Sybille Matthey; Stefan Aebi; Hans Jörg Altermatt; Rolf Jaggi
Journal:  BMC Med Genomics       Date:  2008-04-19       Impact factor: 3.063

View more
  9 in total

1.  MNX1 Is Oncogenically Upregulated in African-American Prostate Cancer.

Authors:  Li Zhang; Jianghua Wang; Yongquan Wang; Yiqun Zhang; Patricia Castro; Longjiang Shao; Arun Sreekumar; Nagireddy Putluri; Nilanjan Guha; Saligrama Deepak; Arunkumar Padmanaban; Chad J Creighton; Michael Ittmann
Journal:  Cancer Res       Date:  2016-08-30       Impact factor: 12.701

2.  Homeobox protein HB9 binds to the prostaglandin E receptor 2 promoter and inhibits intracellular cAMP mobilization in leukemic cells.

Authors:  Sarah Wildenhain; Deborah Ingenhag; Christian Ruckert; Özer Degistirici; Martin Dugas; Roland Meisel; Julia Hauer; Arndt Borkhardt
Journal:  J Biol Chem       Date:  2012-10-08       Impact factor: 5.157

3.  The homeobox transcription factor HB9 induces senescence and blocks differentiation in hematopoietic stem and progenitor cells.

Authors:  Deborah Ingenhag; Sven Reister; Franziska Auer; Sanil Bhatia; Sarah Wildenhain; Daniel Picard; Marc Remke; Jessica I Hoell; Andreas Kloetgen; Dennis Sohn; Reiner U Jänicke; Gesine Koegler; Arndt Borkhardt; Julia Hauer
Journal:  Haematologica       Date:  2018-08-09       Impact factor: 9.941

4.  Motor Neuron and Pancreas Homeobox 1 (MNX1) Is Involved in Promoting Squamous Cervical Cancer Proliferation via Regulating Cyclin E.

Authors:  Li Xiao; Li Hong; Wenfei Zheng
Journal:  Med Sci Monit       Date:  2019-08-22

Review 5.  Currarino syndrome: a comprehensive genetic review of a rare congenital disorder.

Authors:  Gabriel C Dworschak; Heiko M Reutter; Michael Ludwig
Journal:  Orphanet J Rare Dis       Date:  2021-04-09       Impact factor: 4.123

6.  An induced pluripotent stem cell t(7;12)(q36;p13) acute myeloid leukemia model shows high expression of MNX1 and a block in differentiation of the erythroid and megakaryocytic lineages.

Authors:  Tina Nilsson; Ahmed Waraky; Anders Östlund; Susann Li; Anna Staffas; Julia Asp; Linda Fogelstrand; Jonas Abrahamsson; Lars Palmqvist
Journal:  Int J Cancer       Date:  2022-06-03       Impact factor: 7.316

7.  A Novel Three-Colour Fluorescence in Situ Hybridization Approach for the Detection of t(7;12)(q36;p13) in Acute Myeloid Leukaemia Reveals New Cryptic Three Way Translocation t(7;12;16).

Authors:  Abdulbasit Naiel; Michael Vetter; Olga Plekhanova; Elena Fleischman; Olga Sokova; Grigory Tsaur; Jochen Harbott; Sabrina Tosi
Journal:  Cancers (Basel)       Date:  2013-03-11       Impact factor: 6.639

Review 8.  Paediatric acute myeloid leukaemia with the t(7;12)(q36;p13) rearrangement: a review of the biological and clinical management aspects.

Authors:  Sabrina Tosi; Yasser Mostafa Kamel; Temitayo Owoka; Concetta Federico; Tony H Truong; Salvatore Saccone
Journal:  Biomark Res       Date:  2015-10-05

9.  Motor neuron and pancreas homeobox 1/HLXB9 promotes sustained proliferation in bladder cancer by upregulating CCNE1/2.

Authors:  Mingkun Chen; Rongpei Wu; Gang Li; Cundong Liu; Lei Tan; Kanghua Xiao; Yunlin Ye; Zike Qin
Journal:  J Exp Clin Cancer Res       Date:  2018-07-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.